| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. (CLRB) has 4 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. CLRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 12.8K | $39.6K | - | |
| CEO | 11.6K | $36.1K | - | |
| CFO | 6.4K | $19.9K | - | |
| Dir | 10 | $31.00 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Caruso James V | President And CEO | Sell | 34,000 | $1.20 | $40,704.80 | -13.7% | |
| Nov 14, 2017 | Neis John | Director | Sell | 5,214 | $1.49 | $7,790.76 | -0.8% | |
| Nov 29, 2016 | Neis John | Director | Buy | 333,333 | $1.49 | $496,666.17 | +111.9% | |
| Oct 31, 2016 | Hertzberg Richard | Significant Owner | Sell | 21,000 | $2.03 | $42,609.00 | -7.0% | |
| Apr 21, 2016 | Hertzberg Richard | Significant Owner | Buy | 238,500 | $2.12 | $504,793.24 | +66.3% | |
| Apr 20, 2016 | Berns Paul L | Director | Buy | 117,371 | $2.12 | $248,826.52 | New | |
| Apr 20, 2016 | Caruso James V | President And CEO | Buy | 46,948 | $2.12 | $99,529.76 | +7,825% | |
| Apr 20, 2016 | Neis John | Director | Buy | 234,742 | $2.12 | $497,653.04 | +371.2% | |
| Apr 20, 2016 | Hill Stephen A | Director | Buy | 9,390 | $2.12 | $19,906.80 | +1,772% | |
| Dec 31, 2015 | Awm Investment Company, Inc.72 | 10% Owner | Sell | 100,000 | $0.69 | $69,019.07 | -73.9% |